Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 12 of 56
The slide uses a Venn diagram to represent the intersection of genetic targets and a bar chart to demonstrate the efficacy of patient selection.
Pitch deck · solution · cite_precedent · dense density
Slide locked Sign in to view
Slide schematic 7/7
chart 1/1 diagram 1/1 metric 4/4 title 1/1
Components 7
bar-grouped venn big-number big-number big-number big-number headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1